By Carol Chouinard, Ashley Bieck, Tiffany Hales, Jim Armstrong, Erin Schulte, and Jon Bergman

Rather than positioning itself as an EHR company, Oracle is increasingly positioning itself as an AI-native healthcare platform company. During the summit, Oracle reinforced a strategy centered on data, infrastructure, interoperability, and agentic AI, with the EHR becoming one component of a broader healthcare technology ecosystem that is integrated with other aspects of medicine and life sciences.

The most important question coming out of the conference was not whether Oracle can compete with Epic today, but whether healthcare's next transformation cycle will be driven by AI, data platforms, and consumer-centric experiences rather than traditional EHR functionality alone. 

1. The next-generation EHR sparked genuine interest

In August, Oracle announced a new EHR designed for ambulatory providers, which is now live for early adopters. During the summit, Oracle demonstrated the new EHR experience, and it received some of the most positive feedback from the event. The company also provided an advance look at a new EHR for other areas of care, such as oncology. 

 Some highlights of the next-gen EHR include:

• Modern web-native architecture with no Citrix dependency and easy transferability to mobile experiences
• Cleaner provider experience
• AI-assisted workflows
• Voice-enabled interactions
• User interface with seamless flow from one tool to another
• Redesigned classic tools such as timeline and summary views and modernized inbox/messaging workflows

Oracle appears to be balancing innovation with continuity by allowing legacy customers to run new tools overlaid on the older Millennium EHR, and by preserving many familiar backend tools while redesigning the user experience layer.

Although several early adopters acknowledged the platform is not yet ready for broad-scale deployment, many expressed confidence in its direction and highlighted Oracle's responsiveness to customer feedback.

2. AI is being positioned as the next-generation clinical assistant

Oracle consistently framed AI as an extension of the care team rather than an additional burden. Some current uses of AI include ambient documentation, patient message drafting, clinical decision support, coding optimization, denials prevention, and clinical workflow guidance. 

Perhaps most compelling were demonstrations showing documentation captured earlier in the workflow, reducing downstream rework, lowering denials, and improving revenue cycle performance without creating additional clinician effort.

In particular, Beacon Health's ambient listening deployment was repeatedly cited as a successful example of rapid adoption and provider acceptance, with one leader calling the initiative "the easiest rollout they have ever had."

3. AI has shifted from vision to operationalization

Across customer presentations, it became clear that the challenge is no longer generating AI ideas but prioritizing, building, validating, and scaling them. 

Some common themes included:

• KPI-driven use case selection
• Clinical and operational governance
• Robust non-production validation environments
• AI accuracy scoring and monitoring
• Cross-functional teams building agents

Organizations emphasized that successful AI programs depend as much on workflow design, change management, and consultative problem solving as technical development.

4. Oracle is becoming increasingly EHR-agnostic

One of the more interesting strategic developments was Oracle's willingness to extend beyond its own EHR footprint. For example, the company has launched an EHR-agnostic patient portal and now offers support for standards-based interoperability. It has also encouraged broader data-sharing initiatives and FHIR-centered architectures.

The patient portal vision was particularly notable, enabling longitudinal patient records across participating organizations, regardless of underlying EHR.

This aligns directly with Oracle co-founder and current CTO Larry Ellison's recurring message: "The health record belongs to the patient, not the software vendor." Other company leaders, such as Seema Verma, also made statements about inviting their competitors (Epic, others) to the open conference.

5. Oracle's strategic bet is the integrated stack

Oracle's strongest message centered on combining OCI infrastructure, healthcare data platforms, AI services, clinical applications, and security and governance all into a single ecosystem.

The clear message was that AI performance ultimately depends on data architecture, and Oracle sees its advantage in controlling more of the technology stack than any other healthcare vendor. 

Areas of tension remain

Despite the optimism during the summit, several realities surfaced, including:

• Rollout remains slower than originally anticipated.
• Clients are queued up, waiting for "the semantic layer," which is needed for new AI capabilities.
• Ambulatory capabilities are still maturing.
• Partner readiness and certification models remain unclear.
• Third-party ecosystem growth trails Epic.

In general, Oracle's vision is becoming increasingly coherent, with execution and market adoption remaining the primary questions.

What matters most

The conference suggested Oracle is pursuing a long-term strategy built around three ideas:

1. Healthcare data should be interoperable and patient-centered.
2. AI agents will become embedded in everyday clinical and operational workflows.
3. Successful organizations will combine data, infrastructure, applications, and AI into a unified platform.

Unlike Epic, which continues to lead through scale and ecosystem maturity, Oracle is betting that the next era of healthcare IT will be defined by AI-enabled workflows, intelligent automation, and consumer-centric data experiences.

Bottom line

The strongest signal from the summit was not that Oracle has solved its market challenges. It was that Oracle has developed a clearer narrative for the future of healthcare technology: a platform where AI, data, interoperability, and workflow converge. Whether that vision translates into broad adoption remains uncertain, but the company appears significantly further along in articulating its strategy than it was even a year ago.